文献速递口腔颌面外科

2015-2019年美国牙医阿片类药物处方轨迹分析

Trajectories of opioid prescribing by general dentists, specialists, and oral and maxillofacial surgeons in the United States, 2015-2019.
PubMed 文献 · J Am Dent Assoc · 2023-11-19

该研究基于IQVIA纵向处方数据,对2015至2019年美国活跃处方牙医(含全科、专科及口腔颌面外科医生)进行组基轨迹建模,识别出8种阿片处方轨迹并归为5类。研究发现60%牙医处方率下降30%至83%,但3.4%的牙医持续高频处方;高频处方者内部亦存在异质性。

要点

  • 60%牙医阿片处方率下降30%至83%,但3.4%持续高频处方。
  • 持续高频处方者中仅7.5%快速下降,且该组口腔颌面外科医生比例更低。
  • 需额外信息以更好指导政策与临床决策。

核心结论

  • 牙医阿片处方率存在差异,60%牙医处方率下降30%至83%,但3.4%持续高频处方。

研究设计与样本

  • 基于IQVIA纵向处方数据集(2015-2019)的组基轨迹建模研究,模型1纳入199,145名处方者,模型2纳入6,845名持续高频处方者。

主要发现

  • 模型1识别8种轨迹归为5类:非处方者14.8%、低处方者46.0%、下降者7.3%、中高处方者28.5%、持续高频者3.4%。
  • 下降者处方率从2015年29.4%降至2019年5.1%,持续高频者从54.6%降至44.7%。
  • 模型2识别4种轨迹,其中快速下降组占7.5%,口腔颌面外科医生比例更低(13.0% vs 18.4%),Medicaid患者更多(2.5% vs 1.0%),2015年处方率更高(95.5% vs 91.6%)(P < .001)。

临床怎么用

  • 部分牙医持续高频处方阿片类药物,提示需额外信息以更好指导政策与临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite decreases in opioid prescribing from 2016 through 2019, some dentists (general, specialists, oral and maxillofacial surgeons) in the United States continue to prescribe opioids at high rates. The authors' objective was to define dentists' trajectories of opioid prescribing. METHODS: The authors identified actively prescribing dentists from the IQVIA Longitudinal Prescription data set, from 2015 through 2019. Group-based trajectory modeling identified opioid prescribing trajectories on the basis of dentists' annual prescribing rates for the overall sample (model 1) and for high prescribers (model 2). The authors used χ2 or Mann-Whitney U tests to characterize the model 2 trajectory groups. RESULTS: In model 1 (n = 199,145 prescribers), group-based trajectory modeling identified 8 trajectories that were grouped into 5 categories. A total of 14.8% were nonprescribers who composed less than 1% of all prescriptions, low prescribers (3 groups; 46.0%) prescribed at low rates (2015: 5.5%-16.9%; 2019: 1.5%-11.9%), decliners (7.3%) decreased prescribing rapidly (2015: 29.4%; 2019: 5.1%), moderately high prescribers (2 groups; 28.5%) prescribed moderately (2015: 28.7% and 39.2%; 2019: 18.1% and 28.8%), and consistently high prescribers (3.4%) prescribed at high rates (2015: 54.6%; 2019: 44.7%). In model 2, from consistently high prescribers (n = 6,845), 4 trajectories were identified. Of these 4 groups, 1 group (7.5%) declined prescribing rapidly. The groups did not differ meaningfully; however, the rapid decliners included fewer oral and maxillofacial surgeons (13.0% vs 18.4%), saw more Medicaid patients (2.5% vs 1.0%), and had higher opioid prescribing rates in 2015 (95.5% vs 91.6%) (P < .001 for all). CONCLUSIONS: The authors identified variations in dentists' opioid prescribing rates. Although 60% of dentists decreased prescribing rates by 30% through 83%, 3.4% of dentists consistently prescribed at high rates. PRACTICAL IMPLICATIONS: Some dentists continue to prescribe opioids at high levels, indicating that additional information is needed to better inform policy and clinical decision making.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Khouja T, Shah NH, Suda KJ, et al. Trajectories of opioid prescribing by general dentists, specialists, and oral and maxillofacial surgeons in the United States, 2015-2019. J Am Dent Assoc. 2023. PMID: 37988047. doi:10.1016/j.adaj.2023.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。